Abstract

Prior studies have attempted to ascertain the feasibility of using EHR to emulate data elements necessary in clinical trials. However, few studies have focused on assessing the utility of both structured and unstructured (i.e., abstracted) data from oncology specific EHR systems for such purposes. This study examined critical elements of recent oncology clinical trials to assess the degree to which these real-world data (RWD) can be reasonably used to retrospectively replicate the information needed in trials.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call